Compare Payoneer Global Inc (PAYO) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Payoneer Global Inc vs Teladoc Health Inc — how do they compare? Payoneer Global Inc trades at $7.11 (market cap $2.42B), while Teladoc Health Inc trades at $6.09 (market cap $1.14B). The key difference: Payoneer Global Inc is far larger — about 2.1× Teladoc Health Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals.
| PAYO | TDOC | |
|---|---|---|
Market Cap | $2.42B | $1.14B |
Sector | Technology | Health |
52-Week High | $7.18 | $9.72 |
52-Week Low | $4.27 | $4.47 |
Enterprise Value | $2.16B | $1.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Payoneer Global (PAYO) trades at $7.13, down 0.56% on the day, with a market cap of approximately $2.3 billion. The stock shows mixed technical signals with a bullish moving average trend but neutral oscillators. Fundamentally, revenue grew to $821 million in 2025 with a 79.4% gross margin, though net income margin declined to 5.83%. Recent news highlights the pending acquisition by Nuvei for $7.40 per share, with multiple law firms investigating the fairness of the deal price.
The acquisition offer at $7.40 provides near-term upside potential, but investor sentiment is cautious due to legal scrutiny. Long-term growth prospects remain positive with expanding global operations, though earnings volatility and competitive pressures present risks. Analyst consensus is bullish with 60% buy ratings, but the stock faces execution risks in integrating the India tech hub and maintaining B2B growth momentum.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
